Nanostring technologies inc..

Generated Orders for ~ 50 Spatial Biology Instruments, Representing 65% Growth Year-over-Year, Including Orders for More than 25 CosMx Spatial Molecular Imagers NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended …

Nanostring technologies inc.. Things To Know About Nanostring technologies inc..

Sep 30, 2023 · SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2023. The Company also announced it had reached agreement with holders to exchange approximately $216 million, or 94 ... COVID-19 VACCINATION REQUIREMENT: NanoString has a COVID-19 vaccination policy that applies to ALL U.S. employees (regardless of work location), onsite contractors and visitors except as ...SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2023. The Company also announced it had reached agreement with holders to exchange approximately $216 million, or 94 ...NanoString contact info: Phone number: (206) 378-6266 Website: www.nanostring.com What does NanoString do? NanoString Technologies is a provider of life science tools for translational research. The company was founded in …SEATTLE, Wash October 22, 2009 - NanoString Technologies, Inc., a privately held life sciences company marketing a molecular barcoding detection system, today announced that the National Cancer Institute (NCI) is employing its nCounter™ Analysis System at two of its core labs. One system was purchased by the NCI Center for Cancer Research (CCR) …

May 17, 2023 · 10x Genomics filed its patent infringement lawsuit against NanoString in Germany in March 2022.Despite the risk of an injunction and the significant repercussions it could have on researchers ... Apr 18, 2022 · Dr. Rob Hershberg steps down from Board after seven years of service. SEATTLE-- (BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the appointment of Dr. Teresa (Teri) Foy to the Board of Directors, effective April 18, 2022.

NanoString Technologies seeks the best and the brightest to join us in our mission to provide innovative tools and technologies to researchers and scientists around the globe. Working at NanoString provides the opportunity to contribute to the discovery and development of new therapies for better patient outcomes.

About NanoString Technologies, Inc. NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter ® Analysis System has been employed in life sciences research since it was first introduced in 2008 and has been cited in more than 3,300 peer-reviewed …NanoString Technologies, Inc. (NSTG) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 0.5557 -0.0243 (-4.19%) At close: 04:00PM EST 0.5541 -0.00 (-0.29%) May 17, 2023 · SEATTLE & MUNICH, May 17, 2023--(BUSINESS WIRE)--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today responded to ... SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2023. The Company also announced it had reached agreement with holders to exchange approximately $216 million, or 94 ...

Invisible Fence Inc. is a leading provider of innovative pet containment and lifestyle solutions. With over 40 years of experience, Invisible Fence Inc. has developed products that are designed to keep pets safe and secure in their own yard...

NanoString Technologies, Inc. | 48,646 followers on LinkedIn. Mapping the universe of biology 🧬 | NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for ...

PLEASANTON, Calif., Nov. 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. TXG, a leader in single cell and spatial biology, announced today that a jury in the U.S. District Court for the District of ...The legal fight between 10x Genomics and NanoString Technologies has intensified. 10x Genomics is a California-based biotechnology company specializing in gene sequencing technology. According to its quarterly report , the company filed a patent lawsuit in Germany against its American competitor NanoString on March 9, 2022, following two ...NANOSTRING TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share amounts) (Unaudited) Three Months Ended. March 31, 2023 2022 Revenue: Instruments $ 11,370 $ 9,103 Consumables 19,776 17,468 Services and other 4,659Mar 1, 2022 · SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and year ended December 31, 2021. About NanoString Technologies, Inc. NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides three platforms that allow ...Nov 1, 2023 · NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx® Digital Spatial Profiler is a flexible and consistent solution combining the power of whole tissue imaging with gene expression and protein ...

Phone: 1 888-358-NANO (6266) Fax: 206-378-6288 General Investor Inquiries: [email protected] NanoString Technologies, Inc. NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 3,300 peer-reviewed publications.NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the fourth quarter and year ended December 31, 2018. Fourth Quarter Financial Highlights Product and service revenue of $23.6 million , 12% year-over-year growth …NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The company's technology enables a wide variety of basic …NanoString Technologies, Inc. | 48,641 followers on LinkedIn. Mapping the universe of biology 🧬 | NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for ...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to exclusively license select nCounter-based diagnostic assets and rights to Veracyte Inc. for $50 million in cash and Veracyte stock, plus up to $10 million in cash ...

NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx® Digital Spatial Profiler is a flexible and consistent solution combining the power of whole tissue imaging with gene expression and protein ...SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. 43rd Annual Canaccord …NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.November 19, 2023 — 08:21 pm EST. Written by RTTNews.com for RTTNews ->. (RTTNews) - NanoString Technologies Inc. (NSTG) said it respectfully disagreed with the verdict of the jury in the U.S ...NANOSTRING TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share amounts) (Unaudited) Three Months Ended. June 30, Six Months Ended. June 30, 2023 2022 2023 2022 Revenue: Instruments $ 17,629 $ 9,538 $ 28,999Dec 3, 2019 · SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to exclusively license select nCounter-based diagnostic assets and rights to Veracyte Inc. for $50 million in cash and Veracyte stock, plus up to $10 million in cash ...

Latest NanoString Technologies Inc (NSTG:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

Generated Orders for ~ 50 Spatial Biology Instruments, Representing 65% Growth Year-over-Year, Including Orders for More than 25 CosMx Spatial Molecular Imagers NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended …

Oct 10, 2023 · SEATTLE, October 10, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and ... SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the second quarter ended June 30, 2023.Jun 30, 2023 · NANOSTRING TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share amounts) (Unaudited) Three Months Ended. June 30, Six Months Ended. June 30, 2023 2022 2023 2022 Revenue: Instruments $ 17,629 $ 9,538 $ 28,999 Company Description: NanoString Technologies develops, manufactures and markets technologies that unlock scientifically valuable and clinically actionable information from minute amounts of biological material. The company makes a complex genomic analysis device called the nCounter Analysis System, the device uses tissue extracted from a …About NanoString Technologies, Inc. NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides three platforms that allow researchers to map the universe of biology. The nCounter® Analysis System, cited in more than 5,300 peer-reviewed publications, offers …NanoString contact info: Phone number: (206) 378-6266 Website: www.nanostring.com What does NanoString do? NanoString Technologies is a provider of life science tools for translational research. The company was founded in …Dec 13, 2022 · NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx® Digital Spatial Profiler, cited in more than 170 peer-reviewed publications, is a flexible and consistent solution combining the power of ... Apr 18, 2022 · Dr. Rob Hershberg steps down from Board after seven years of service. SEATTLE-- (BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the appointment of Dr. Teresa (Teri) Foy to the Board of Directors, effective April 18, 2022.

Complete NanoString Technologies Inc. stock information by Barron's. View real-time NSTG stock price and news, along with industry-best analysis. The nCounter® Inflammation Panel lets you perform multiplex gene expression analysis on human or mouse samples with more than 200 genes focused on the study of inflammation. These genes represent a broad range of relevant pathways related to inflammation that include apoptosis, EGF, interleukin signaling, Ras, T cell receptor, and Toll-like ...NanoString Technologies Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. NanoString Technologies Inc’s trailing 12-month revenue is $162.5 million with a -102.4% profit margin. Year-over-year quarterly sales growth most recently was 63.1%. Analysts expect adjusted earnings to reach $ …SEATTLE-- (BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational …Instagram:https://instagram. ways to earn cryptotfra retirementnasdaq nrdsearnings calendar sandp 500 Source: NanoString Technologies, Inc. View All News. Investor Contact. Phone: 1 888-358-NANO (6266) Fax: 206-378-6288 General Investor Inquiries: [email protected]. Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After …Joseph M. Beechem, Ph.D., has served as the chief scientific officer and senior vice president of Research and Development at NanoString since April 2012. Before joining NanoString, Dr. Beechem held various positions at Life Technologies, a publicly traded biotechnology tools company. He most recently served as vice president, head of Advanced ... long term treasury etfrandm auctions About NanoString Technologies, Inc. NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company’s nCounter ® Analysis System is used in life sciences research and has been cited in more than 4,300 peer-reviewed publications. best dave ramsey book to start with Latest NanoString Technologies Inc (NSTG:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.Jun 30, 2023 · NANOSTRING TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share amounts) (Unaudited) Three Months Ended. June 30, Six Months Ended. June 30, 2023 2022 2023 2022 Revenue: Instruments $ 17,629 $ 9,538 $ 28,999